|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Babak Behnam, MD, PhD (NSF International, USA) , Maria Vliora, PhD (University of Thessaly, Greece) , Sumel Ashique, PhD (Asst. Professor, Bengal College of Pharmaceutical Sciences & Research, Durgapur, West Bengal, India) , Farzad Taghizadeh-Hesary, PhD (TOKAI Research Institute for Environment and Sustainability (TRIES), Tokai University, Japan)Publisher: Elsevier - Health Sciences Division Imprint: Elsevier - Health Sciences Division ISBN: 9780443405358ISBN 10: 0443405352 Pages: 220 Publication Date: 12 January 2026 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Forthcoming Availability: Not yet available This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release. Table of Contents1. Mitochondria: Origin, Structure, and Function 2. Mitochondrial Metabolism and Trafficking in Cancer 3. Mitochondrial Genome and Cancer 4. Mitochondrial-nuclear Crosstalk and Its Role in Cancer 5. Mitochondria and Tumor Microenvironment 6. Mitochondria and Cancer Stem Cells 7. Mitochondria, Exosome, Cancer 8. Mitochondria, Microbiota, Cancer 9. MiRNAs and Their Impacts on Cancer Cell’s Mitochondria 10. Mitochondria and Cancer Prevention 11. Mitochondria and Cancer Diagnosis 12. Mitochondrial Metabolism as a Prognostic Biomarker (Mitochondria and Cancer Progression) 13. Mitochondria, Tumor Microenvironment, and Radioresistance 14. Mitochondria and Resistance to Chemotherapy 15. Mitochondria and Resistance to Targeted Therapies 16. Mitochondria and Resistance to Immunotherapy 17. Mitochondria Enhancing Strategies in Cancer 18. Advances in Targeted Anti-mitochondrial Therapies 19. Applying Magnetic Fields to Target MitochondriaReviewsAuthor InformationDr. Babak Behnam has completed his PhD degree at the University College London (UCL) in Human Genetics. Then he served as postdoctoral research fellow at the University of Michigan School of Medicine and University of Central Florida (UCF). He joined the Undiagnosed Disease Program (UDP) at NIH while doing an American Board of Medical Genetics and Genomic in clinical biochemical laboratory genetics at NHGRI, NIH. He joined NSF International as a clinical research organization. Dr. Behnam has published more than 70 peer-reviewed papers and has nine patents to his name throughout his career; also, has served as an Editorial Board Member of several scientific journals. He has enthusiasm in translational research, neuroscience & neurogenetics, and biochemical & molecular mechanisms utilizing advanced technological improvements in biochemical genetics, genomics, and NGS platforms. Also, he has an experience and interest in clinical research, and regulatory and scientific analysis of clinical trials. Dr. Vliora Maria is a Molecular Biologist with extensive background in molecular biology and integrative physiology. She has previously studied mutations of immunoglobulins in Chronic Lymphocytic Leukemia patients, and ALK mutations and downstream signaling in Neuroblastoma. Dr. Vliora has a PhD in Biomedical Research from University of Thessaly, Greece and University of Brescia, Italy. She has worked on the development of biocompatible/biodegradable bioscaffolds for targeting adipose tissue as well as on potential nanomedical treatments for brain tumors as well as blood malignancies. Her research work is now focusing on environmental influences that can affect human health and on the use of novel biodegradable bio-scaffolds for allografting adipose stem cells in humans. She collaborated with reputable organizations (WHO, ILO) on projects aiming to enhance human health and wellbeing. She now works as a Project Manager on EU funded projects. Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & 20 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing 13 books under CRC Press, Taylor & Francis, Springer and Wiley. Dr. Farhad Taghizadeh-Hesary is an economics and finance associate professor at Tokai University in Japan. He is the co-founder and vice president of the International Society for Energy Transition Studies (ISETS), Editor-in-Chief of the Journal of Environmental Assessment Policy and Management (World Scientific), and associate editor of several academic journals. He has authored over 350 peer-reviewed journal papers and book chapters and edited 25 books by major publishers in various fields, including green finance and sustainability, energy economics, and policy. He was included on Clarivate’s list of Highly Cited Researchers. In 2023, he received the Commendation and Medal for Science and Technology from the Minister of Education, Culture, Sports, Science, and Technology of Japan for his outstanding research achievements. He holds a Ph.D. in economics from Keio University, Japan. Tab Content 6Author Website:Countries AvailableAll regions |
||||